Literature DB >> 6415211

Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes.

M Brownlee, S Pongor, A Cerami.   

Abstract

The chronic tissue damage associated with long-term diabetes mellitus may arise in part from in situ immune complex formation by accumulated immunoglobulins and/or antigens bound to long-lived structural proteins that have undergone excessive nonenzymatic glycosylation. In this report, we have tested this hypothesis using nonenzymatically glycosylated collagen. Binding of both albumin and IgG averaged four times the amount bound to unmodified collagen. Both albumin and IgG (anti-BSA) bound to nonenzymatically glycosylated collagen retained their ability to form immune complexes in situ with free antibody and antigen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415211      PMCID: PMC2187146          DOI: 10.1084/jem.158.5.1739

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

Review 1.  CHEMISTRY OF NONENZYMIC BROWNING. I. THE REACTION BETWEEN ALDOSES AND AMINES.

Authors:  T M REYNOLDS
Journal:  Adv Food Res       Date:  1963

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 3.  Chemistry of nonenzymic browning. II.

Authors:  T M Reynolds
Journal:  Adv Food Res       Date:  1965

4.  Glycosylated collagen.

Authors:  H Rosenberg; J B Modrak; J M Hassing; W A Al-Turk; S J Stohs
Journal:  Biochem Biophys Res Commun       Date:  1979-11-28       Impact factor: 3.575

5.  Tetradecanoyl phorbol acetate stimulates latent collagenase production by cultured human endothelial cells.

Authors:  D Moscatelli; E Jaffe; D B Rifkin
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

6.  In situ immune complex formation and glomerular injury.

Authors:  W G Couser; D J Salant
Journal:  Kidney Int       Date:  1980-01       Impact factor: 10.612

7.  Studies of diabetic nephropathy in animals and man.

Authors:  S M Mauer; M W Steffes; A F Michael; D M Brown
Journal:  Diabetes       Date:  1976       Impact factor: 9.461

8.  Immunopathology of renal extracellular membranes in diabetes mellitus. Specificity of tubular basement-membrane immunofluorescence.

Authors:  K Miller; A F Michael
Journal:  Diabetes       Date:  1976-08       Impact factor: 9.461

9.  Diabetic cataract formation: potential role of glycosylation of lens crystallins.

Authors:  V J Stevens; C A Rouzer; V M Monnier; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

10.  Experimental glomerulonephritis induced by in situ formation of immune complexes in glomerular capillary wall.

Authors:  S M Golbus; C B Wilson
Journal:  Kidney Int       Date:  1979-08       Impact factor: 10.612

View more
  29 in total

1.  An in vitro study on the role of metal catalyzed oxidation in glycation and crosslinking of collagen.

Authors:  G B Sajithlal; P Chithra; G Chandrakasan
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

2.  Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs.

Authors:  A W Stitt; C He; S Friedman; L Scher; P Rossi; L Ong; H Founds; Y M Li; R Bucala; H Vlassara
Journal:  Mol Med       Date:  1997-09       Impact factor: 6.354

3.  Urinary excretion of glycated albumin in insulin-dependent diabetic patients with normal urinary albumin excretion.

Authors:  G Pagano; A Chiambretti; V Calefato; M Tomalino; G Cecchini; A Bruno; P Cavallo-Perin
Journal:  Acta Diabetol Lat       Date:  1991 Jan-Mar

4.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.

Authors:  M Cogné; J L Preud'homme; M Bauwens; G Touchard; P Aucouturier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

5.  Non-enzymatic glycation of epidermal proteins of the stratum corneum in diabetic patients.

Authors:  I Márová; J Záhejský; H Sehnalová
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

6.  Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy.

Authors:  J F Poduslo; G L Curran
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

7.  Rat bovine serum albumin (BSA) nephritis. VI. The influence of chemically altered antigen.

Authors:  T Yamamoto; S Miyazaki; K Kawasaki; E Yaoita; I Kihara
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

8.  Genetic risk factors in diabetic retinopathy.

Authors:  L L Stewart; L L Field; S Ross; R G McArthur
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

9.  Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.

Authors:  P J Beisswenger; L L Moore; T Brinck-Johnsen; T J Curphey
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 10.  Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease.

Authors:  Susan J Zieman; David A Kass
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.